This Breast Cancer Hijacks Immune Cells to Grow Its Own Nerve Supply

University of Oklahoma researchers found that triple-negative breast cancer, one of the hardest types to treat, recruits immune cells that release a protein drawing nerves into the tumor to fuel its growth and treatment resistance. Blocking that signal with a commercially available drug significantly slowed tumor growth in mice, and real patient data showed a matching pattern.